Endocrine therapy: what the agencies decided

10 molecules in ATC class L02 with a published cross-agency decision record.

Molecule	Decisions	Agencies	Class
enzalutamide	52	12	Endocrine therapy
darolutamide	38	15	Endocrine therapy
apalutamide	28	12	Endocrine therapy
abiraterone	27	10	Endocrine therapy
fulvestrant	19	7	Endocrine therapy
relugolix	17	10	Endocrine therapy
triptorelin	17	4	Endocrine therapy
elacestrant	14	10	Endocrine therapy
degarelix	12	6	Endocrine therapy
letrozole	10	4	Endocrine therapy